Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

Publication | Open Access

DOI Full Paper Access

126

Citations

References

2012

Year

Giorgio V. Scagliotti, Silvia Novello, Joan H. Schiller, Vera Hirsh, Lecia V. Sequist, Jean‐Charles Soria, Joachim von Pawel, Brian Schwartz, Reinhard von Roemeling, Alan B. Sandler

Clinical Lung Cancer

Non–small-cell Lung CancerOncologyMedicineLocally AdvancedPhase IiiMetronomic TherapyPharmacotherapyCancer TreatmentPharmacologyLung Cancer